Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,607,000
-39,000 (-2.37%)
At close: Nov 28, 2025
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 74.39 trillion as of November 28, 2025. Its market cap has increased by 4.10% in one year.
Market Cap
74.39T
Enterprise Value
73.65T
Revenue
5.50T
Ranking
n/a
PE Ratio
46.61
Stock Price
1,607,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 74.39T, an increase of 680.77%. That is a compound annual growth rate of 25.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 74.67T | 10.55% |
| Dec 30, 2024 | 67.54T | 24.87% |
| Dec 28, 2023 | 54.09T | -7.43% |
| Dec 29, 2022 | 58.43T | -2.20% |
| Dec 30, 2021 | 59.75T | 9.32% |
| Dec 30, 2020 | 54.65T | 90.76% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 10, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 41.00T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 11.02T |
| ABL Bio | 9.56T |
| Yuhan | 8.91T |
| Peptron | 7.44T |
| LigaChem Biosciences | 6.76T |
| HLB Co., Ltd. | 6.03T |